Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Nishiwaki S, Miyamura K, Ohashi K, Kurokawa M, Taniguchi S, Fukuda T, Ikegame K, Takahashi S, Mori T, Imai K, Iida H, Hidaka M, Sakamaki H, Morishima Y, Kato K, Suzuki R, Tanaka J; Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Nishiwaki S, et al. Among authors: miyamura k. Ann Oncol. 2013 Jun;24(6):1594-602. doi: 10.1093/annonc/mds655. Epub 2013 Jan 31. Ann Oncol. 2013. PMID: 23372050 Free article.
Effect of graft sources on allogeneic hematopoietic stem cell transplantation outcome in adults with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a Japanese Society of Hematopoietic Cell Transplantation retrospective analysis.
Ohashi K, Nagamura-Inoue T, Nagamura F, Tojo A, Miyamura K, Mori T, Kurokawa M, Taniguchi S, Ishikawa J, Morishima Y, Atsuta Y, Sakamaki H. Ohashi K, et al. Among authors: miyamura k. Int J Hematol. 2014 Sep;100(3):296-306. doi: 10.1007/s12185-014-1632-9. Epub 2014 Aug 2. Int J Hematol. 2014. PMID: 25085253
Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR.
Imahashi N, Suzuki R, Fukuda T, Kakihana K, Kanamori H, Eto T, Mori T, Kobayashi N, Iwato K, Sakura T, Ikegame K, Kurokawa M, Kondo T, Iida H, Sakamaki H, Tanaka J, Kawa K, Morishima Y, Atsuta Y, Miyamura K. Imahashi N, et al. Among authors: miyamura k. Bone Marrow Transplant. 2013 Jan;48(1):56-62. doi: 10.1038/bmt.2012.84. Epub 2012 Jun 18. Bone Marrow Transplant. 2013. PMID: 22705800
Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).
Tanaka J, Kanamori H, Nishiwaki S, Ohashi K, Taniguchi S, Eto T, Nakamae H, Minagawa K, Miyamura K, Sakamaki H, Morishima Y, Kato K, Suzuki R, Nishimoto N, Oba K, Masauzi N. Tanaka J, et al. Among authors: miyamura k. Bone Marrow Transplant. 2013 Nov;48(11):1389-94. doi: 10.1038/bmt.2013.68. Epub 2013 May 13. Bone Marrow Transplant. 2013. PMID: 23665820
Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S, Iida H, Uchida T, Ikegame K, Takahashi S, Kato K, Kawa K, Nagamura-Inoue T, Morishima Y, Sakamaki H, Kodera Y; Japan Society for Hematopoietic Cell Transplantation. Atsuta Y, et al. Among authors: miyamura k. Ann Oncol. 2014 Feb;25(2):435-41. doi: 10.1093/annonc/mdt558. Epub 2014 Jan 7. Ann Oncol. 2014. PMID: 24399081 Free article.
Effect of Granulocyte Colony-Stimulating Factor-Combined Conditioning in Cord Blood Transplantation for Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia: A Retrospective Study in Japan.
Konuma T, Takahashi S, Uchida N, Kuwatsuka Y, Yamasaki S, Aoki J, Onishi Y, Aotsuka N, Ohashi K, Mori T, Masuko M, Nakamae H, Miyamura K, Kato K, Atsuta Y, Kato S, Asano S, Takami A, Miyazaki Y; Adult Myelodysplastic Syndrome and Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Konuma T, et al. Among authors: miyamura k. Biol Blood Marrow Transplant. 2015 Sep;21(9):1632-40. doi: 10.1016/j.bbmt.2015.05.009. Epub 2015 May 16. Biol Blood Marrow Transplant. 2015. PMID: 25985920 Free article. Clinical Trial.
Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation.
Inamoto Y, Nishida T, Suzuki R, Miyamura K, Sao H, Iida H, Naoe T, Maruyama F, Hirabayashi N, Hamaguchi M, Iseki T, Kami M, Yano K, Takeyama H, Morishita Y, Morishima Y, Kodera Y. Inamoto Y, et al. Among authors: miyamura k. Bone Marrow Transplant. 2007 Jan;39(1):25-30. doi: 10.1038/sj.bmt.1705543. Epub 2006 Nov 20. Bone Marrow Transplant. 2007. PMID: 17115063
Disease stage stratified effects of cell dose in unrelated BMT for hematological malignancies: a report from Japan Marrow Donor Program.
Inamoto Y, Miyamura K, Okamoto S, Akiyama H, Iida H, Eto T, Morishima Y, Kawa K, Kikuchi A, Nagatoshi Y, Tanaka J, Ashida T, Hirokawa M, Tsuchida M, Mori S. Inamoto Y, et al. Among authors: miyamura k. Bone Marrow Transplant. 2011 Sep;46(9):1192-202. doi: 10.1038/bmt.2010.281. Epub 2010 Nov 8. Bone Marrow Transplant. 2011. PMID: 21057551
A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies.
Terakura S, Atsuta Y, Sawa M, Ohashi H, Kato T, Nishiwaki S, Imahashi N, Yasuda T, Murata M, Miyamura K, Suzuki R, Naoe T, Ito T, Morishita Y; Nagoya Blood and Marrow Transplantation Group. Terakura S, et al. Among authors: miyamura k. Ann Oncol. 2011 Aug;22(8):1865-71. doi: 10.1093/annonc/mdq673. Epub 2011 Feb 2. Ann Oncol. 2011. PMID: 21289367 Free article. Clinical Trial.
432 results